Miliary Pneumocystis jiroveci pneumonia in a patient living with HIV

Yasemin Çakır Kıymaz1, Seyit Ali Büyüktuna1

  • 1Department of Infectious Diseases, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Turkey.

Insights

Miliary Pneumocystis pneumonia (PJP) is a rare presentation in people with HIV. This case highlights the importance of considering PJP in HIV patients with miliary patterns on imaging, even when tuberculosis is suspected.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • HIV Medicine

Background:

  • Pneumocystis jirovecii pneumonia (PJP) is a significant opportunistic infection in individuals with advanced HIV.
  • Typical PJP presents with bilateral infiltrates on chest imaging.
  • Miliary involvement, a rare manifestation, can complicate diagnosis.

Observation:

  • A 32-year-old person living with HIV presented with cough, sputum, and weight loss.
  • Chest radiography revealed a miliary pattern, initially suggesting miliary tuberculosis.
  • Diagnosis was confirmed via Pneumocystis jirovecii Polymerase Chain Reaction (PCR) positivity.

Findings:

  • The patient was diagnosed with miliary PJP, an uncommon clinical presentation.
  • PCR testing proved crucial in differentiating miliary PJP from miliary tuberculosis.

Implications:

  • This case underscores the diagnostic challenge posed by rare PJP presentations.
  • Early and accurate diagnosis of miliary PJP is vital for appropriate treatment in immunocompromised individuals.
  • Highlights the need for considering PJP in HIV patients with miliary patterns, irrespective of initial differential diagnoses.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
215
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
237
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
313
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K